ACTG research projects are examining novel proteins that regulate responses to ethanol in ex vivo, rodent or invertebrate studies. These proteins have not been examined by alcohol researchers before. ACTG investigators use preclinical rodent models to determine if these proteins regulate behavioral responses to ethanol and contribute to alcohol use disorders. Such studies are necessary to determine if any of these proteins are potential drug targets for the development of new therapies to treat alcoholism and if they contribute to genetic risk of alcoholism.

Our Mission

Discovering new approaches to pharmacologic treatment
and detection of risk for alcohol use disorders.